drugset / Trial / NCT00024245

10-Propargyl-10-Deazaaminopterin Plus Probenecid in Treating Patients With Advanced Solid Tumors

NCT00024245

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Probenecid may increase the effectiveness of 10-propargyl-10-deazaaminopterin by making tumor cells more sensitive to the drug. PURPOSE: Phase I trial to study the effectiveness of combining 10-propargyl-10-deazaaminopterin and probenecid in treating patients who have advanced solid tumors.

Timeline

Start
2001-05
Primary completion
Completion
2003-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Pralatrexate Other / unclassified Intravenous
Subject Probenecid Small molecule Intravenous